ATXI · Avenue Therapeutics, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“However, as described below, substantial doubt about the Company’s ability to continue as a going concern exists. These factors individually and collectively cause substantial doubt about the Company’s ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Nov 6, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of ATXI in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns ATXI
13F quarter Dec 31, 2024| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 192,628 | 5.85% |
| Insiders (Forms 3, 4, 5) | 439,830 | 13.35% |
| 13D/G-only blocks | 126,420 | 3.84% |
| Remaining | 2,536,089 | 76.97% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 3,294,967, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of ATXI
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
Fortress Biotech, Inc.
13D
CIK 1429260 · Holding company · Jan 2, 2026
Item 4 purpose: Other
not summed
|
439,955 | ||
| 1.1 |
|
439,733 | ||
| 2 |
Ikarian Capital, LLC
13G
CIK 1778253 · Registered investment adviser · Dec 31, 2025
Rule 13d-1(b), qualified institution, not summed
|
130,820 | ||
| 2.1 |
Ikarian Capital, LLC
13F
CIK 1778253 · Registered investment adviser · Dec 31, 2024
|
140,000 | ||
| 3 |
ARMISTICE CAPITAL, LLC
13G
CIK 1601086 · Registered investment adviser · Dec 31, 2024
Rule 13d-1(b), qualified institution
|
100,400 | ||
| 4 |
BOOTHBAY FUND MANAGEMENT, LLC
13F
CIK 1549230 · Registered investment adviser · Dec 31, 2024
|
41,089 | ||
| 5 |
Robert Davidow
13G
CIK 2002210 · Unknown · May 2, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed May 2, 2024
|
17,206 | ||
| 6 |
SABBY MANAGEMENT, LLC
13G
CIK 1535610 · Unknown · Dec 31, 2023
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Dec 31, 2023
|
8,814 | ||
| 7 |
UBS Group AG
13F
CIK 1610520 · Bank · Dec 31, 2024
|
7,920 | ||
| 8 |
Tower Research Capital LLC (TRC)
13F
CIK 1533421 · Unknown · Dec 31, 2024
|
3,096 | ||
| 9 |
WELLS FARGO & COMPANY/MN
13F
CIK 72971 · Bank · Dec 31, 2024
|
500 | ||
| 10 |
|
97 | ||
| 11 |
BANK OF AMERICA CORP /DE/
13F
CIK 70858 · Bank · Dec 31, 2024
|
14 | ||
| 12 |
SBI Securities Co., Ltd.
13F
CIK 1851815 · Non-US institution · Dec 31, 2024
|
9 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.